{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:16Z","timestamp":1787022016832,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190653","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T14:00:34Z","timestamp":1514988034000},"page":"e0190653","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo"],"prefix":"10.1371","volume":"13","author":[{"given":"Takeo","family":"Tatsuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-5560","authenticated-orcid":true,"given":"Masahiro","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"AS Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"BWS Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.103.4_Supplement.373S","article-title":"Natural history and epidemiology of malignant mesothelioma","volume":"103","author":"KH Antman","year":"1993","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"MA Bonelli","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"ref5","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"BM Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.humpath.2015.02.006","article-title":"Prognostic factors in malignant pleural mesothelioma","volume":"46","author":"B Davidson","year":"2015","journal-title":"Hum Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"AW Musk","year":"2011","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis","volume":"11","author":"FJH Brims","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","article-title":"Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma","volume":"11","author":"A Bill\u00e9","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.2017.20","article-title":"Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma","volume":"116","author":"S Muruganandan","year":"2017","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1272874","article-title":"Update on Malignant Pleural Mesothelioma","volume":"32","author":"N Campbell","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.hoc.2005.09.010","article-title":"An overview of chemotherapy for mesothelioma","volume":"19","author":"LM Krug","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: Propensity score matching analysis","volume":"35","author":"DB Nelson","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"M de Perrot","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"LM Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin\/Pemetrexed and radiotherapy","volume":"71","author":"S B\u00f6l\u00fckbas","year":"2011","journal-title":"Lung Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"W Weder","year":"2007","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years","volume":"103","author":"JS Friedberg","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"ref20","first-page":"285","article-title":"Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins","volume":"21","author":"IF Pryme","year":"2006","journal-title":"Histol Histopathol"},{"key":"ref21","first-page":"7","article-title":"Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration","author":"JA Ochoa-Alvarez","year":"2012","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagen.2009.04.020","article-title":"Induction of apoptosis by Polygonatum odoratum lectin and its molecular mechanisms in murine fibrosarcoma L929 cells","volume":"1790","author":"B Liu","year":"2009","journal-title":"Biochim Biophys Acta\u2014Gen Subj"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/md12073994","article-title":"Adenovirus carrying gene encoding Haliotis discus discus sialic acid binding lectin induces cancer cell apoptosis","volume":"12","author":"X Yang","year":"2014","journal-title":"Mar Drugs"},{"key":"ref24","first-page":"4877","article-title":"Isolation and characterization of Rana catesbeiana lectin and demonstration of the lectin-binding glycoprotein of rodent and human tumor cell membranes","volume":"47","author":"K Nitta","year":"1987","journal-title":"Cancer Res"},{"key":"ref25","first-page":"920","article-title":"Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily","volume":"54","author":"K Nitta","year":"1994","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/glycob\/3.1.37","article-title":"Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs","volume":"3","author":"K Nitta","year":"1993","journal-title":"Glycobiology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fonc.2014.00139","article-title":"Cancer-selective induction of apoptosis by leczyme","volume":"4","author":"T Tatsuta","year":"2014","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/nar\/20.6.1371","article-title":"A pyrimidine-guanine sequence-specific ribonuclease from Rana catesbeiana (bullfrog) oocytes","volume":"20","author":"Y di Liao","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/bi00382a018","article-title":"Amino acid sequence of sialic acid binding lectin from frog (Rana catesbeiana) eggs","volume":"26","author":"K Titani","year":"1987","journal-title":"Biochemistry"},{"key":"ref30","first-page":"421415","article-title":"Leczyme: a new candidate drug for cancer therapy","volume":"2014","author":"T Tatsuta","year":"2014","journal-title":"Biomed Res Int. Hindawi Publishing Corporation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s000180050206","article-title":"Biochemistry of frog ribonucleases","volume":"54","author":"M Irie","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3892\/ijo.2013.2092","article-title":"Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells","volume":"43","author":"T Tatsuta","year":"2013","journal-title":"Int J Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3892\/ijo.2016.3656","article-title":"RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3\/7 signaling pathway in human breast cancer cells","volume":"49","author":"Y Kariya","year":"2016","journal-title":"Int J Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3892\/ijo.2013.2192","article-title":"Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL","volume":"44","author":"T Tatsuta","year":"2014","journal-title":"Int J Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"42466","DOI":"10.18632\/oncotarget.17198","article-title":"Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma","volume":"8","author":"T Satoh","year":"2017","journal-title":"Oncotarget"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.18632\/oncotarget.1760","article-title":"Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer","volume":"5","author":"S Kawabata","year":"2014","journal-title":"Oncotarget"},{"key":"ref37","first-page":"3671","article-title":"Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma","volume":"59","author":"JL Tonkinson","year":"1999","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"T-C Chou","year":"2010","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"RB Mokhtari","year":"2015","journal-title":"Oncotarget"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e40521","DOI":"10.1371\/journal.pone.0040521","article-title":"Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma","volume":"7","author":"OD R\u00f8e","year":"2012","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/annonc\/mdm501","article-title":"Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)","volume":"19","author":"B Castagneto","year":"2008","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.2007.14.7611","article-title":"Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma","volume":"26","author":"PA J\u00e4nne","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/OTT.S113598","article-title":"Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date","volume":"10","author":"PA Levin","year":"2017","journal-title":"Onco Targets Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"G Zalcman","year":"2016","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T01:27:20Z","timestamp":1603589240000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190653"}},"subtitle":[],"editor":[{"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190653","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}